Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.5M
-
Number of holders
-
206
-
Total 13F shares, excl. options
-
43.3M
-
Shares change
-
-795K
-
Total reported value, excl. options
-
$3.01B
-
Value change
-
-$56.7M
-
Put/Call ratio
-
0.79
-
Number of buys
-
90
-
Number of sells
-
-100
-
Price
-
$69.55
Significant Holders of AtriCure, Inc. - Common Stock (ATRC) as of Q3 2021
233 filings reported holding ATRC - AtriCure, Inc. - Common Stock as of Q3 2021.
AtriCure, Inc. - Common Stock (ATRC) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.3M shares
of 49.5M outstanding shares and own 87.51% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.18M shares), BlackRock Inc. (3.65M shares), FRED ALGER MANAGEMENT, LLC (3.35M shares), ALLIANCEBERNSTEIN L.P. (2.91M shares), Invesco Ltd. (2.27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.02M shares), Champlain Investment Partners, LLC (1.22M shares), CREDIT SUISSE AG/ (1.14M shares), MACQUARIE GROUP LTD (1.09M shares), and STATE STREET CORP (1.01M shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.